Tracks blood markers in heart failure patients using pumps or transplant
Follows adults with advanced heart failure supported by mechanical heart pumps over 25 years.
Plain-language title generated from the registry record
Registry title: Prognostic Value of BNP in MCS - a 25 Year Follow up Study
Key facts
- Where
- Copenhagen, DenmarkSee the site
Where in Denmark
- RigshospitaletCopenhagen, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Copenhagen University Hospital, Rigshospitalet
- Trial code
- NCT04377854
- Record updated
- 5 May 2021
- Original description
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy.Read full original descriptionShow less
The Prognostic Value of proBNP in Patients Supported With Durable Mechanical Circulatory Assist Devices - a 25 Year Follow up Study.
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy.
Patients will be followed up for 25 years after inclusion.
Inclusion: All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark; Age>18 years.
Exclusion: No consent.